Objective: The Cochrane review conducted in 2001 re-established the usefulness of external cephalic version (ECV). The success rate for ECV using epidural anesthesia or spinal anesthesia is reported to be 35 to 86%. In this study, we examined the effectiveness of epidural anesthesia for ECV.
Introduction
Breech presentation at term occurs in 3 to 4% of all pregnancies. 1 In case of breech presentation, it has been shown that selective cesarean delivery provides a better perinatal prognosis for children than vaginal delivery. [2] [3] [4] The Cochrane review in 2001 re-established the usefulness of external cephalic version (ECV). The American Congress of Obstetricians and Gynecologists Committee has also recommended reducing breech presentation. 3 On the basis of these suggestions, we are proposing to our patients the use of ECV as the third option, in addition to the choice of either trial breech delivery or selective cesarean delivery.
Mancuso et al. 5 have reported the effectiveness of epidural anesthesia for ECV for breech presentation in late pregnancy. The success rate of ECV with epidural anesthesia was 59.2%. We began using epidural anesthesia for ECV since 2003. This study intends to examine its effectiveness for success of ECV.
Methods
The study was carried out at National Defense Medical College Hospital between 1 January 2001 and 30 June 2009. The study protocol was approved by the institutional ethics committee, and written informed consent was obtained for all procedures described in the protocol. Pregnant women meeting the following criteria were selected as the study subjects: 35 to 36 weeks of gestation, breech or transverse presentation, single pregnancy, aged X18 years, showing a reassuring fetal status pattern in the non-stress test and estimated fetal weight of 2000 to 4000 g. The subjects were hospitalized and ultrasonographically examined for placental location, umbilical insertion site, presence/absence of uterine myoma, anomaly and nuchal cord. Those with placenta previa, early rupture of membranes, uterine anomaly or severe fetal anomaly and those in whom delivery was initiated were excluded from the study.
Before ECV, each subject was intravenously administered 500 ml of hydroxyethylated starch for the expansion of circulating plasma volume and continuously administered ritodrine hydrochloride as a tocolytic agent at a rate of 67 mg min -1 . In the anesthesia group, an epidural catheter was inserted at the L1/L2 intervertebral space, followed by the administration of 3 ml of 0.25% bupivacaine. After confirming the absence of adverse reactions such as a decrease in blood pressure, another 10 ml of 0.25% bupivacaine was infused. Blood pressure was monitored every 1 min during the first 10 min after drug administration, then every 2 min for another 10 min and every 5 min thereafter. Each subject was placed in the Trendelenburg position after the level of anesthesia reached T10.
An obstetrician stood on the right-hand side of a subject when performing ECV. ECV was basically performed by forward rotation, and if it failed, by backward rotation. No limitation was set on the procedural time. We did not perform a transvaginal fetus-lifting procedure in any of the patients. When a resident physician was to perform ECV, he or she was supervised by a senior attending physician. After completion of ECV, the mother and fetus were evaluated for approximately 4 h. Fetal well-being was evaluated using the non-stress test before and after ECV. If ECV failed, cesarean delivery was then scheduled for approximately 38 weeks of gestation.
From 2001 to 2003, we used just the tocolytic agent in the setting of ECV. Subsequent to 2003, we began using epidural anesthesia, and this constituted the primary difference between our two groups. The anesthesia and non-anesthesia groups were compared in terms of the rate of vaginal delivery, overall rate of cesarean delivery and rate of neonatal asphyxia.
Statistical analyses were performed using Student's t-test and the w 2 test. Logistic regression was used for multivariate analysis to adjust for potential confounding factors (Statview, version 5.0, SAS Institute Inc., Cary, NC, USA). P<0.05 was statistically significant. Because of the natural experiment nature of this study with a specific convenience sample, we did not conduct any a priori sample size calculations.
Results
During the study period, 86 women with non-cephalic presentation were eligible for ECV and were included in the study. The nonanesthesia group consisted of 34 women who underwent ECV between January 2001 and March 2003, in whom ritodrine hydrochloride, a tocolytic agent, was administered alone, and 52 women who underwent ECV between April 2003 and June 2009, in whom a tocolytic agent and an epidural anesthetic were used, constituted the anesthesia group. There were no significant differences in age, parity, body mass index and placental location between the two groups ( Table 1) .
The results are shown in Table 2 . The success rate for ECV was 55.9% (19/34 patients) in the non-anesthesia group and 78.8% (41/52 patients) in the anesthesia group, showing a significant difference between the two groups (odds ratio 1.75, 95% confidence interval 1.26 to 2.44). There was no case of non-reassuring fetal status immediately after ECV in either of the groups. In the non-anesthesia group, 1 of the 19 patients with successful ECV developed uterine infection and thus underwent cesarean delivery. In the anesthesia group, 6 of the 41 patients with successful ECV underwent cesarean delivery. The reasons included occipitoposterior presentation during delivery in four patients, non-reassuring fetal status during delivery in one patient and recurrence of breech presentation in one patient. The overall rate of cesarean delivery as a measure of delivery outcome was 50.0% (17/34 patients) in the non-anesthesia group and 32.7% (17/52 patients) in the anesthesia group, not indicating a significant contribution of ECV to the reduction of cesarean delivery (odds ratio 0.49, 95% confidence interval 0.23 to 1.18). There was no case of neonatal asphyxia during delivery or transient tachypnea of the newborn after delivery in either of the groups.
Univariate analysis of the potential effect of different variables on success rates of ECV is shown in Table 3 . Maternal age, parity, body mass index, placental location and epidural anesthesia were significant at P<0.05. Multivariate analysis found that none of the factors had statistically significant effects of ECV success rates except for epidural anesthesia (Table 4) .
Discussion
We have used epidural anesthesia for ECV and observed a significant difference in the success rate for ECV between the nonanesthesia group (55.9%) and the anesthesia group (78.8%). This result may contribute to increase the options of delivery method at the next pregnancy. The success rates for ECV at individual medical institutions are reported to be 35 to 86%. 6, 7 One of the possible reason for the variable success rates is the influence of auxiliary procedures, such as spontaneous rotation, epidural anesthesia and spinal anesthesia. Although the effectiveness of spinal anesthesia has also been shown, its success rate is only 44.0 to 66.7%. 8, 9 Carlan et al.
10
carried out a retrospective study and reported an ECV success rate of 59.4% in patients receiving epidural anesthesia and 24.3% in those not receiving anesthesia. Schorr et al. 11 carried out a randomized study and reported an ECV success rate of 69.0% in the epidural anesthesia group and 32.0% in the non-anesthesia group. Furthermore, Kristern et al. 5 used epidural anesthesia with 2% lidocaine and 100 mg of fentanyl for ECV and reported a success rate of 59.2% in those with epidural anesthesia and 33.3% in those without epidural anesthesia (relative risk 1.8, 95% confidence interval 1.2 and 2.8, P<0.05). On the other hand, Dugoff et al. 9 showed no significant difference in the success rate for ECV with and without spinal anesthesia (Table 5) .
Although no adverse reactions to epidural anesthesia have been reported, the anesthesia may cause decreased uterine and placental perfusion, leading to fetal hypoxia by decreasing maternal blood pressure, depending on the depth of anesthesia. Adequate monitoring is thus required when using epidural anesthesia for ECV. In a survey among 805 patients conducted by Collins et al. 12 , there was no case of uterine rupture or fetal damage associated with ECV.
Healey et al. 13 performed ECV at a gestational age of X36 weeks and obtained a success rate of 39%. In comparison, Hutton et al.
14 performed ECV at a gestational age of p36 weeks and obtained an extremely high success rate of 86.2%, although the frequency of recurrent breech presentation was also significantly increased. Hofmeyr et al. 4 , however, have shown that performing ECV at a gestational age of X36 weeks can reduce both breech delivery and cesarean delivery without affecting perinatal prognosis for children. As the success rate for ECV is expected to decrease at a gestational age of X37 weeks due to fetal growth, we assumed that performing ECV at 36 weeks would result in the highest success rate. We then showed that the use of epidural anesthesia enables the safe and reliable performance of ECV.
Newman et al. 15 identified the following five predictive factors for successful ECV: previous history of delivery, placental location, cervical length, position of fetal head and estimated fetal weight. They showed that the success rate is particularly high if the placenta is located in the posterior wall. In the present study, however, high success rates were obtained regardless of placental location. This is probably because sufficient muscular relaxation 16 showed that an AFI of p10 cm is associated with a significant decrease in the success rate for ECV. Other new approaches have also been proposed from the viewpoint of fetal stimulation, such as application of acoustic stimulus and infusion of artificial amniotic fluid. 17 In the present investigation, there was no case in which ECV failed but the fetus spontaneously turned to the cephalic presentation. Similarly, Ben-Meir et al. 18 reported that only 6.6% of women with unsuccessful ECV showed spontaneous rotation from breech to cephalic presentation.
In our analysis, none of the pregnant women who were given sufficient information about breech presentation and ECV wished to undergo breech vaginal delivery. The use of epidural anesthesia during ECV contributed to an increased success rate for ECV and a consequent decrease in cesarean delivery. From these results, further studies should be performed for ECV to be performed more safely and reliably. Meanwhile, based on our and other's results, regional anesthesia should be considered in the setting of ECV to increase its success. Abbreviations: CI, confidence interval; ND, not significant difference; OR, odds ratio; RR, relative risk.
Does ECV need epidural anesthesia?
